Relationship of proximal renal tubular dysgenesis and fetal liver injury in neonatal hemochromatosis

Pediatric Research

Volumn 67, Issue 2, 2010, Pages 188-193

  Bonilla, Silvana F ^a   Melin Aldana, Hector ^a   Whitington, Peter F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

ARTICLE; AUTOPSY; DISEASE SEVERITY; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; KIDNEY; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; KIDNEY PROXIMAL TUBULE DYSGENESIS; KIDNEY PROXIMAL TUBULE MALFORMATION; KIDNEY TUBULE DISORDER; LIVER; LIVER CELL; LIVER FAILURE; MORPHOMETRICS; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; CASE CONTROL STUDY; CONGENITAL MALFORMATION; DOWN REGULATION; FEMALE; GESTATIONAL AGE; IMMUNOHISTOCHEMISTRY; LIVER DISEASE; METABOLISM; PATHOLOGY; PREGNANCY; PRENATAL DEVELOPMENT;

ANGIOTENSINOGEN; AUTOPSY; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; GESTATIONAL AGE; HEMOCHROMATOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES, PROXIMAL; LIVER; LIVER DISEASES; PREGNANCY;

EID: 77449160786     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181c2df69     Document Type: Article

References (31)

1. Knisely AS, Mieli-Vergani G, Whitington PF 2003 Neonatal hemochromatosis. Gastroenterol Clin North Am 32:877-889
2. Hoogstraten J, de Sa DJ, Knisely AS 1990 Fetal liver disease may precede extrahepatic siderosis in neonatal hemochromatosis. Gastroenterology 98:1699-1701
3. Whitington PF 2007 Neonatal hemochromatosis: a congenital alloimmune hepatitis. Semin Liver Dis 27:243-250
4. Whitington PF, Kelly S 2008 Outcome of pregnancies at risk for neonatal hemo-chromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 121:e1615-e1621
5. Bale PM, Kan AE, Dorney SF 1994 Renal proximal tubular dysgenesis associated with severe neonatal hemosiderotic liver disease. Pediatr Pathol 14:479-489
6. Johal JS, Thorp JW, Oyer CE 1998 Neonatal hemochromatosis, renal tubular dysgenesis, and hypocalvaria in a neonate. Pediatr Dev Pathol 1:433-437
7. Morris S, Akima S, Dahlstrom JE, Ellwood D, Kent A, Falk MC 2004 Renal tubular dysgenesis and neonatal hemochromatosis without pulmonary hypoplasia. Pediatr Nephrol 19:341-344
8. Allanson JE, Hunter AG, Mettler GS, Jimenez C 1992 Renal tubular dysgenesis: a not uncommon autosomal recessive syndrome: a review. Am J Med Genet 43:811-814
9. Whitington PF 2006 Fetal and infantile hemochromatosis. Hepatology 43:654-660
10. Gomez RA, Norwood VF 1995 Developmental consequences of the renin-angiotensin system. Am J Kidney Dis 26:409-431
11. Guron G, Friberg P 2000 An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18:123-137
12. Pryde PG, Sedman AB, Nugent CE, Barr M Jr 1993 Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3:1575-1582
13. Stec DE, Davisson RL, Haskell RE, Davidson BL, Sigmund CD 1999 Efficient liver-specific deletion of a floxed human angiotensinogen transgene by adenoviral delivery of Cre recombinase in vivo. J Biol Chem 274:21285-21290
14. Whitington PF, Malladi P, Melin-Aldana H, Azzam R, Mack CL, Sahai A 2005 Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr Res 57:837-844
15. Fleming S, Lindop GB, Gibson AA 1985 The distribution of epithelial membrane antigen in the kidney and its tumours. Histopathology 9:729-739
16. Oberg KC, Pestaner JP, Bielamowicz L, Hawkins EP 1999 Renal tubular dysgenesis in twin-twin transfusion syndrome. Pediatr Dev Pathol 2:25-32
17. Tanguay RM, Valet JP, Lescault A, Duband JL, Laberge C, Lettre F, Plante M 1990 Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I). Am J Hum Genet 47:308-316
18. Morris BJ, Iwamoto HS, Reid IA 1979 Localization of angiotensinogen in rat liver by immunocytochemistry. Endocrinology 105:796-800
19. Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF 2004 Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287:G1035-G1043
20. Hyde DM, Tyler NK, Plopper CG 2007 Morphometry of the respiratory tract: avoiding the sampling, size, orientation, and reference traps. Toxicol Pathol 35:41-48
21. Weibel ER, Hsia CC, Ochs M 2007 How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol 102:459-467
22. Genest DR, Lage JM 1991 Absence of normal-appearing proximal tubules in the fetal and neonatal kidney: prevalence and significance. Hum Pathol 22:147-153
23. Gribouval O, Gonzales M, Neuhaus T, Aziza J, Bieth E, Laurent N, Bouton JM, Feuillet F, Makni S, Ben Amar H, Laube G, Delezoide AL, Bouvier R, Dijoud F, Ollagnon-Roman E, Roume J, Joubert M, Antignac C, Gubler MC 2005 Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet 37:964-968
24. Piper JM, Ray WA, Rosa FW 1992 Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol 80:429-432
25. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Petersen J, Adams MA 1994 Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 45:485-492
26. Olson AL, Perlman S, Robillard JE 1990 Developmental regulation of angiotensino-gen gene expression in sheep. Pediatr Res 28:183-185
27. Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA 1995 Angioten-sin II regulates nephrogenesis and renal vascular development. Am J Physiol 269:F110-F115
28. Bernstein J, Barajas L 1994 Renal tubular dysgenesis: evidence of abnormality in the renin-angiotensin system. J Am Soc Nephrol 5:224-227
29. Avner ED, Sweeney WE Jr, Piesco NP, Ellis D 1985 Growth factor requirements of organogenesis in serum-free metanephric organ culture. In Vitro Cell Dev Biol 21:297-304
30. Ghevaert C, Wilcox DA, Fang J, Armour KL, Clark MR, Ouwehand WH, Williamson LM 2008 Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombo-cytopenia. J Clin Invest 118:2929-2938
31. Rand EB, Karpen SJ, Kelly S, Mack CL, Malatack JJ, Sokol RJ, Whitington PF 2009 Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr 155:566-571